We make pure vitamin K2 MK-7

a doctor working in a lab doing research on vitamin k2

A short history of Kappa

In 2006, two brilliant chemists - Inger Reidun Aukrust Ph.D. and Marcel Sandberg Ph.D – noticed a growing need for vitamin K2. And of course, where there’s need, there’s opportunity. So they founded Kappa Bioscience, with the aim of finding a way to make pure, all vitamin K2 MK-7 on a large scale, without the large cost.

houses in a rural area in Norway where vitamin k2 is produced

In 2009, they did just that, setting the foundation for the success of K2VITAL®, and Kappa’s remarkably rapid commercial growth at the same time. Not bad for three years’ work.

To this day, we proudly continue that legacy of innovation. We’re still a bioscience company through and through, with teams of passionate experts and a state-of-the-art GMP-certified API contract laboratory that helps us make pure vitamin K2 MK-7 in ground-breaking new forms, with unmatched quality and stability. And we can make it available to everyone.

And that’s where it got us:

The start of the Kappa story. Headquarters established in Oslo with offices in the US and Germany. Dr. Inger Reidun Aukrust, together with her team, discovered a process to produce all-trans vitamin K2, MK-7 in a strictly controlled process, producing exceptionally pure MK-7.

2006
Launch of the K2VITAL® product brand covering K2 MK-7 powders and oils

2011
Launch of K2VITAL Delta –- the world’s first and only double-microencapsulated vitamin K2 securing stability in any formulation.

2013
Kappa acquires Synthetica, a long-term partner specialiszed in drug and vitamin synthesis, analysis and R&D

2016
Kappa acquires ppm.ingredients

2016
Kappa crowned NutraChampion at Nutraingredients-Asia for its scientific and commercial MK-7 innovations

2018
Kappa Bioscience signs research agreements with universities and hospitals around the globe

2019
Verdane Capital Partners becomes majority owner

2019
Listed as one of NORWAY’s FASTEST GROWING TECHNOLOGY businesses in Deloitte’s annual roundup

2020
Kappa Bioscience continues its geographical expansion by establishing US-based entity

2020
Kappa joins Ecologi and workforce becomes climate positive

2021
Kappa Bioscience is acquired by Balchem

2022

About Kappa:

Kappa Bioscience AS was founded in Oslo, Norway in 2006 when a brilliant scientist discovered the synthesis of pure, all-bioactive vitamin K2 MK-7, an essential vitamin needed to direct calcium around our bodies, and keep hearts, bones, and lots of other things healthy.

From vitamin K2 and turn-key solutions, to research and marketing initiatives, to product launches and growth strategies, Kappa Bioscience AS believes in doing it right. That means developing products and services that set new standards of excellence, made with integrity, and through close collaboration.

graphic of a man in a suit with glasses and blue hair

"The Kappa team always goes beyond expectations and is at the core of the health and nutrition space."

Joris Dewit, Senior director business development, LONZA

Our heritage

A short history of Kappa

And that’s where it got us: